Versant Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001560009 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 12, 2021

Total Value: $302M (100.0% shares, 0.0% debt)

Holdings (11)

CRSP CRISPR Therapeutics AG 27.3%

Value $82.33M Shares 508,558 Est. Cost $40.26 Unrealized +202.0%

— Passage Bio, Inc. 21.8%

Value $65.67M Shares 4,959,769 Est. Cost $17.48 Unrealized —

— Aligos Therapeutics, Inc. 15.7%

Value $47.3M Shares 2,320,381 Est. Cost $27.65 Unrealized —

— Gritstone Oncology, Inc. 13.5%

Value $40.63M Shares 4,450,638 Est. Cost $7767.86 Unrealized —

— Adverum Biotechnologies, Inc. 5.9%

Value $17.74M Shares 5,068,233 Est. Cost $9646.10 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 5.1%

Value $15.47M Shares 820,720 Est. Cost $17.05 Unrealized +3.1%

— Akero Therapeutics, Inc. 5.1%

Value $15.33M Shares 617,727 Est. Cost $21200.00 Unrealized —

— Flexion Therapeutics, Inc. 2.7%

Value $8.23M Shares 1,000,000 Est. Cost $10.41 Unrealized —

— Aprea Therapeutics, Inc 2.0%

Value $6.147M Shares 1,259,662 Est. Cost $38780.00 Unrealized —

— CymaBay Therapeutics, Inc. 0.8%

Value $2.371M Shares 543,753 Est. Cost $9871.60 Unrealized —

— Clovis Oncology, Inc. 0.2%

Value $591K Shares 101,855 Est. Cost $56000.00 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CRSP	CRISPR Therapeutics AG	508,558	$82.33M	27.3%	$40.26	+202.0%	Common Shares	H17182108
—	Passage Bio, Inc.	4,959,769	$65.67M	21.8%	$17.48	—	Common Stock	702712100
—	Aligos Therapeutics, Inc.	2,320,381	$47.3M	15.7%	$27.65	—	Common Stock	01626L105
—	Gritstone Oncology, Inc.	4,450,638	$40.63M	13.5%	$7767.86	—	Common Stock	39868T105
—	Adverum Biotechnologies, Inc.	5,068,233	$17.74M	5.9%	$9646.10	—	Common Stock	00773U108
CRNX	Crinetics Pharmaceuticals, Inc.	820,720	$15.47M	5.1%	$17.05	+3.1%	Common Stock	22663K107
—	Akero Therapeutics, Inc.	617,727	$15.33M	5.1%	$21200.00	—	Common Stock	00973Y108
—	Flexion Therapeutics, Inc.	1,000,000	$8.23M	2.7%	$10.41	—	Common Stock	33938J106
—	Aprea Therapeutics, Inc	1,259,662	$6.147M	2.0%	$38780.00	—	Common Stock	03836J102
—	CymaBay Therapeutics, Inc.	543,753	$2.371M	0.8%	$9871.60	—	Common Stock	23257D103
—	Clovis Oncology, Inc.	101,855	$591K	0.2%	$56000.00	—	Common Stock	189464100